Combined chemo-immunotherapy as first-line treatment in patients with advanced/metastatic small cell lung cancer ("extensive disease") - a real-world, multicenter analysis

被引：0
|
作者：
Zellweger, N. [1 ]
Schmid, S. [2 ]
Bertschinger, M. [3 ]
Waibel, C. [4 ]
Cerciello, F. [5 ]
Froesch, P. [6 ]
Mark, M. [7 ]
Bettini, A. [8 ]
Hauptle, P. [9 ]
Blum, V [10 ]
Litke, T. [11 ]
Helfenstein, F. [11 ]
Fruh, M. [2 ]
Mauti, L. [3 ]
Rothschild, S. [1 ,12 ]
机构：
[1] Univ Spital Basel, Med Onkol, Basel, Switzerland
[2] Kantonsspital St Gallen, Onkol & Hamatol, St Gallen, Switzerland
[3] Kantonsspital Winterthur, Med Onkol, Winterthur, Switzerland
[4] Kantonsspital Baden, Onkol & Hamatol, Baden, Switzerland
[5] Inselspital Bern, Med Onkol, Bern, Switzerland
[6] Ist Oncol Svizzera Italiana IOSI, Bellinzona, Switzerland
[7] Kantonsspital Graubunden, Onkol Hamatol, Chur, Switzerland
[8] HFR Freiburg Kantonsspital, Med Onkol, Fribourg, Switzerland
[9] Kantonsspital Baselland, Onkol Hamatol, Liestal, Switzerland
[10] Kantonsspital Luzern, Med Onkol, Luzern, Switzerland
[11] Univ Spital Basel, Dept Klin Forsch, Basel, Switzerland
[12] Univ Spital Base l, Tumorzentrum, Basel, Switzerland
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P673
引用
收藏
页码：207 / 207
页数：1
相关论文
共 50 条
  • [1] Real-world analysis of outcomes of first-line chemo-immunotherapy in patients with extensive disease small cell lung cancer (ED-SCLC)
    Zellweger, N. M.
    Schmid, S.
    Bertschinger, M.
    Waibel, C.
    Cerciello, F. W. F.
    Froesch, P. R.
    Mark, M. T.
    Bettini, A.
    Hauptle, P.
    Blum, V.
    Litke, T.
    Helfenstein, F.
    Frueh, M.
    Mauti, L. A.
    Rothschild, S. I.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1251 - S1251
  • [2] Real-world analysis of outcomes of first- line chemo-immunotherapy in patients with extensive disease small cell lung cancer (ED-SCLC)
    Zellweger, N.
    Schmid, S.
    Bertschinger, M.
    Waibel, C.
    Cerciello, F.
    Frosch, P.
    Mark, M.
    Bettini, A.
    Hauptle, P.
    Blum, V.
    Litke, T.
    Fruh, M.
    Mauti, L.
    Rothschild, S.
    [J]. SWISS MEDICAL WEEKLY, 2022, 152 : 47S - 48S
  • [3] Final Analysis of First-Line Chemo-Immunotherapy in Patients with Advanced Lung Adenocarcinoma: An Italian Real-World Study
    Leonetti, A.
    Perrone, F.
    Puntoni, M.
    Bordi, P.
    Maglietta, G.
    Bria, E.
    Gelsomino, F.
    Gelibter, A.
    Caliman, E.
    Genova, C.
    Guaitoli, G.
    Passiglia, F.
    Montrone, M.
    Oresti, S.
    Pasello, G.
    Roca, E.
    Pilotto, S.
    Cecere, F. L.
    Guida, A.
    Manzo, A.
    Russo, A.
    Rastelli, F.
    Bulotta, A.
    Citarella, F.
    Toschi, L.
    Zoratto, F.
    Cortinovis, D. L.
    Paoloni, F.
    Follador, A.
    Carta, A.
    Camerini, A.
    Di Maio, M.
    Tiseo, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S610 - S610
  • [4] Real-World Outcomes of Patients with Advanced Lung Adenocarcinoma Treated with First-Line Chemo-Immunotherapy in Italy
    Perrone, A. Leonetti F.
    Puntoni, M.
    Bordi, P.
    Maglietta, G.
    Carpana, C.
    Gelsomino, F.
    Passiglia, F.
    Genova, C.
    Montrone, M.
    Caliman, E.
    Cerea, G.
    Pasello, G.
    Cecere, F.
    Manzo, A.
    Adamo, V.
    Citarella, F.
    Toschi, L.
    Gelibter, A.
    Rastelli, F.
    Carta, A.
    Guida, A.
    Camerini, A.
    Paoloni, F.
    Bertolini, F.
    Tiseo, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S338 - S339
  • [5] Chemo-immunotherapy as first-line treatment for small-cell lung cancer
    Farid, Saira
    Liu, Stephen V.
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [6] Real-World Efficacy and Safety of Thoracic Radiotherapy after First-Line Chemo-Immunotherapy in Extensive-Stage Small-Cell Lung Cancer
    Xie, Zhaoliang
    Liu, Jingru
    Wu, Min
    Wang, Xiaohan
    Lu, Yuhan
    Han, Chunyan
    Cong, Lei
    Li, Jisheng
    Meng, Xue
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (11)
  • [7] Chemotherapy or chemo-immunotherapy as first-line treatment for extensive-stage small-cell lung cancer - a meta-analysis
    Chen, Ching-Yi
    Chen, Wang-Chun
    Hung, Chao-Ming
    Wei, Yu-Feng
    [J]. IMMUNOTHERAPY, 2021, 13 (14) : 1165 - 1178
  • [8] Real-world comparison of chemo-immunotherapy and chemotherapy alone in the treatment of extensive-stage small-cell lung cancer
    Lamy, Deborah
    Mouillot, Pierre
    Mariet, Anne-Sophie
    Barnestein, Robby
    Quilot, Fleur-Marie
    Fraisse, Clea
    Ghiringhelli, Francois
    Bonniaud, Philippe
    Zouak, Ayoube
    Foucher, Pascal
    [J]. RESPIRATORY MEDICINE AND RESEARCH, 2024, 86
  • [9] First-line Chemo-Immunotherapy in Advanced Non-Small Cell Lung Cancer with 0-49% PD-L1: A Real-world Experience
    Benetti, B.
    Ferro, A.
    Girardi, F.
    Calvetti, L.
    Pavan, A.
    Mulargiu, C.
    Simionato, F.
    Pretelli, G.
    Lorenzi, M.
    Resi, M. V.
    Marinato, G.
    Dal Maso, A.
    Frega, S.
    Pasello, G.
    Aprile, G.
    Morandi, P.
    Guarneri, V.
    Bonanno, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S341 - S341
  • [10] Keeping it real: implications of real-world treatment outcomes for first-line immunotherapy in metastatic non-small cell lung cancer
    Hsu, Grace G.
    MacKay, Eric
    Scheuer, Nicolas
    Ramagopalan, Sreeram, V
    [J]. IMMUNOTHERAPY, 2021, 13 (18) : 1453 - 1456
12345